AC8 0.00% 4.0¢ auscann group holdings ltd

where to next?, page-709

  1. 1,303 Posts.
    lightbulb Created with Sketch. 170
    None of this chimera will happen to a realistic outcome. You don't get anything going without clinical trials. AusCann is not even talking about any arrangement for future trials. The contract for R&D facility would probably take a while to get signed. The fit-out of the facility probably done by end of next year. I expect zero from AusCann this year. Some capsules might be created but they would be intended for trials only. There won't be any real prescription until the trial is successful.
 
watchlist Created with Sketch. Add AC8 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.